- Home
- FRSX vs CDIO Comparison
FRSX vs CDIO Comparison
Compare FRSX & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- CDIO
- Stock Information
- Founded
- FRSX N/A
- CDIO 2017
- Country
- FRSX Israel
- CDIO United States
- Employees
- FRSX N/A
- CDIO N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FRSX Technology
- CDIO Health Care
- Exchange
- FRSX Nasdaq
- CDIO Nasdaq
- Market Cap
- FRSX 7.1M
- CDIO 6.4M
- IPO Year
- FRSX 2017
- CDIO N/A
- Fundamental
- Price
- FRSX $2.23
- CDIO $4.17
- Analyst Decision
- FRSX
- CDIO
- Analyst Count
- FRSX 0
- CDIO 0
- Target Price
- FRSX N/A
- CDIO N/A
- AVG Volume (30 Days)
- FRSX 72.5K
- CDIO 35.8K
- Earning Date
- FRSX 09-21-2025
- CDIO 11-12-2025
- Dividend Yield
- FRSX N/A
- CDIO N/A
- EPS Growth
- FRSX N/A
- CDIO N/A
- EPS
- FRSX N/A
- CDIO N/A
- Revenue
- FRSX $452,000.00
- CDIO $19,507.00
- Revenue This Year
- FRSX N/A
- CDIO $1,434.82
- Revenue Next Year
- FRSX N/A
- CDIO $4,661.91
- P/E Ratio
- FRSX N/A
- CDIO N/A
- Revenue Growth
- FRSX N/A
- CDIO N/A
- 52 Week Low
- FRSX $1.98
- CDIO $3.22
- 52 Week High
- FRSX $18.41
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- FRSX 64.94
- CDIO 53.40
- Support Level
- FRSX $2.06
- CDIO $3.81
- Resistance Level
- FRSX $2.30
- CDIO $4.63
- Average True Range (ATR)
- FRSX 0.12
- CDIO 0.32
- MACD
- FRSX -0.06
- CDIO 0.03
- Stochastic Oscillator
- FRSX 55.01
- CDIO 36.74
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.